Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Tumour treating fields therapy for glioblastoma: current advances and future directions
O Rominiyi, A Vanderlinden, SJ Clenton… - British journal of …, 2021 - nature.com
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and
continues to portend poor survival, despite multimodal treatment using surgery and …
continues to portend poor survival, despite multimodal treatment using surgery and …
Emerging role of glioma stem cells in mechanisms of therapy resistance
Simple Summary Glioblastoma is among the most lethal cancers in humans. Glioblastomas
exhibit a striking heterogeneity, which is maintained by a highly plastic, adaptable …
exhibit a striking heterogeneity, which is maintained by a highly plastic, adaptable …
A genetic map of the response to DNA damage in human cells
M Olivieri, T Cho, A Álvarez-Quilón, K Li… - Cell, 2020 - cell.com
The response to DNA damage is critical for cellular homeostasis, tumor suppression,
immunity, and gametogenesis. In order to provide an unbiased and global view of the DNA …
immunity, and gametogenesis. In order to provide an unbiased and global view of the DNA …
The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells
Glioblastoma is a universally lethal cancer driven by glioblastoma stem cells (GSC). Here,
we interrogated N 6-methyladenosine (m6A) mRNA modifications in GSCs by methyl RNA …
we interrogated N 6-methyladenosine (m6A) mRNA modifications in GSCs by methyl RNA …
Gradient of developmental and injury response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
Glioblastomas harbor diverse cell populations, including rare glioblastoma stem cells
(GSCs) that drive tumorigenesis. To characterize functional diversity within this population …
(GSCs) that drive tumorigenesis. To characterize functional diversity within this population …
[HTML][HTML] Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy
We test the hypothesis that glioblastoma harbors quiescent cancer stem cells that evade anti-
proliferative therapies. Functional characterization of spontaneous glioblastomas from …
proliferative therapies. Functional characterization of spontaneous glioblastomas from …
Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response
Glioma intratumoral heterogeneity enables adaptation to challenging microenvironments
and contributes to therapeutic resistance. We integrated 914 single-cell DNA methylomes …
and contributes to therapeutic resistance. We integrated 914 single-cell DNA methylomes …
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
Despite its importance in human cancers, including colorectal cancers (CRC), oncogenic
KRAS has been extremely challenging to target therapeutically. To identify potential …
KRAS has been extremely challenging to target therapeutically. To identify potential …
Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming
Cancers commonly reprogram translation and metabolism, but little is known about how
these two features coordinate in cancer stem cells. Here we show that glioblastoma stem …
these two features coordinate in cancer stem cells. Here we show that glioblastoma stem …
Drug resistance in glioblastoma: the two faces of oxidative stress
Glioblastomas (GBM) are the most common primary brain tumor with a median survival of 15
months. A population of cells with stem cell properties (glioblastoma stem cells, GSCs) …
months. A population of cells with stem cell properties (glioblastoma stem cells, GSCs) …